Agios Reports Business Highlights and Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Agios Pharma (AGIO) Misses Q3 EPS by 1c
October 31, 2019 7:08 AM EDTAgios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.81), $0.01 worse than the analyst estimate of ($1.80). Revenue for the quarter came in at $26 million versus the consensus estimate of $35.15 million.
The third quarter was marked by strong commercial execution, now a full year... More
